Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 Sep;39(9):950–954. doi: 10.1136/jcp.39.9.950

Human lung tumours may coexpress different classes of intermediate filaments.

K C Gatter, M S Dunnill, G N Van Muijen, D Y Mason
PMCID: PMC500192  PMID: 3020094

Abstract

Ninety four pulmonary neoplasms were examined immunocytochemically with two or three different monoclonal antibodies against the intermediate filament proteins cytokeratin, neurofilament, vimentin, and desmin. In normal tissues these have a different and non-overlapping distribution, and it is generally believed that tumours maintain the same pattern of expression as the tissues from which they arise. In this report, however, the coexpression of at least two (and less commonly three or four) different intermediate filaments was seen in 40% (37 of 94) of the cases of lung cancer. These results, especially if confirmed in other common types of human malignancy, have considerable implications for the use of anti-intermediate filament antibodies in diagnostic pathology.

Full text

PDF
950

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmannsberger M., Osborn M., Droese M., Weber K., Schauer A. Diagnostic value of intermediate filament antibodies in clinical cytology. Klin Wochenschr. 1984 Feb 1;62(3):114–123. doi: 10.1007/BF01738701. [DOI] [PubMed] [Google Scholar]
  2. Baumal R., Kahn H. J., Bailey D., Phillips M. J., Hanna W. The value of immunohistochemistry in increasing diagnostic precision of undifferentiated tumours by the surgical pathologist. Histochem J. 1984 Oct;16(10):1061–1078. doi: 10.1007/BF01002895. [DOI] [PubMed] [Google Scholar]
  3. Blobel G. A., Gould V. E., Moll R., Lee I., Huszar M., Geiger B., Franke W. W. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest. 1985 Jan;52(1):39–51. [PubMed] [Google Scholar]
  4. Broers J., Huysmans A., Moesker O., Vooijs P., Ramaekers F., Wagenaar S. Small cell lung cancers contain intermediate filaments of the cytokeratin type. Lab Invest. 1985 Jan;52(1):113–115. [PubMed] [Google Scholar]
  5. Caselitz J., Becker J., Seifert G., Weber K., Osborn M. Coexpression of keratin and vimentin filaments in adenoid cystic carcinomas of salivary glands. Virchows Arch A Pathol Anat Histopathol. 1984;403(4):337–344. doi: 10.1007/BF00737284. [DOI] [PubMed] [Google Scholar]
  6. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  7. Gabbiani G., Kapanci Y., Barazzone P., Franke W. W. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol. 1981 Sep;104(3):206–216. [PMC free article] [PubMed] [Google Scholar]
  8. Gatter K. C., Alcock C., Heryet A., Mason D. Y. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet. 1985 Jun 8;1(8441):1302–1305. doi: 10.1016/s0140-6736(85)92794-1. [DOI] [PubMed] [Google Scholar]
  9. Gatter K. C., Dunnill M. S., Pulford K. A., Heryet A., Mason D. Y. Human lung tumours: a correlation of antigenic profile with histological type. Histopathology. 1985 Aug;9(8):805–823. doi: 10.1111/j.1365-2559.1985.tb02868.x. [DOI] [PubMed] [Google Scholar]
  10. Ghosh A. K., Erber W. N., Hatton C. S., O'Connor N. T., Falini B., Osborn M., Mason D. Y. Detection of metastatic tumour cells in routine bone marrow smears by immuno-alkaline phosphatase labelling with monoclonal antibodies. Br J Haematol. 1985 Sep;61(1):21–30. doi: 10.1111/j.1365-2141.1985.tb04056.x. [DOI] [PubMed] [Google Scholar]
  11. Gould V. E. The coexpression of distinct classes of intermediate filaments in human neoplasms. Arch Pathol Lab Med. 1985 Nov;109(11):984–985. [PubMed] [Google Scholar]
  12. Gown A. M., Vogel A. M. Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol. 1985 Oct;84(4):413–424. doi: 10.1093/ajcp/84.4.413. [DOI] [PubMed] [Google Scholar]
  13. Hoefler H., Kerl H., Rauch H. J., Denk H. New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma. Am J Dermatopathol. 1984 Dec;6(6):525–530. doi: 10.1097/00000372-198412000-00002. [DOI] [PubMed] [Google Scholar]
  14. Holthöfer H., Miettinen A., Lehto V. P., Lehtonen E., Virtanen I. Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest. 1984 May;50(5):552–559. [PubMed] [Google Scholar]
  15. Holthöfer H., Miettinen A., Paasivuo R., Lehto V. P., Linder E., Alfthan O., Virtanen I. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest. 1983 Sep;49(3):317–326. [PubMed] [Google Scholar]
  16. Huitfeldt H. S., Brandtzaeg P. Various keratin antibodies produce immunohistochemical staining of human myocardium and myometrium. Histochemistry. 1985;83(5):381–389. doi: 10.1007/BF00509196. [DOI] [PubMed] [Google Scholar]
  17. Lane E. B., Hogan B. L., Kurkinen M., Garrels J. I. Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature. 1983 Jun 23;303(5919):701–704. doi: 10.1038/303701a0. [DOI] [PubMed] [Google Scholar]
  18. Lauder I., Holland D., Mason D. Y., Gowland G., Cunliffe W. J. Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology. 1984 Mar;8(2):259–272. doi: 10.1111/j.1365-2559.1984.tb02340.x. [DOI] [PubMed] [Google Scholar]
  19. Lehto V. P., Miettinen M., Dahl D., Virtanen I. Bronchial carcinoid cells contain neural-type intermediate filaments. Cancer. 1984 Aug 15;54(4):624–628. doi: 10.1002/1097-0142(1984)54:4<624::aid-cncr2820540406>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  20. Lehto V. P., Miettinen M., Virtanen I. A dual expression of cytokeratin and neurofilaments in bronchial carcinoid cells. Int J Cancer. 1985 Apr 15;35(4):421–425. doi: 10.1002/ijc.2910350402. [DOI] [PubMed] [Google Scholar]
  21. Miettinen M., Clark R., Lehto V. P., Virtanen I., Damjanov I. Intermediate-filament proteins in parathyroid glands and parathyroid adenomas. Arch Pathol Lab Med. 1985 Nov;109(11):986–989. [PubMed] [Google Scholar]
  22. Miettinen M., Franssila K., Lehto V. P., Paasivuo R., Virtanen I. Expression of intermediate filament proteins in thyroid gland and thyroid tumors. Lab Invest. 1984 Mar;50(3):262–270. [PubMed] [Google Scholar]
  23. Miettinen M., Lehto V. P., Dahl D., Virtanen I. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract. Lab Invest. 1985 Apr;52(4):429–436. [PubMed] [Google Scholar]
  24. Miettinen M., Lehto V. P., Virtanen I. Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastruct Pathol. 1984;7(2-3):83–107. doi: 10.3109/01913128409141467. [DOI] [PubMed] [Google Scholar]
  25. Molenaar W. M., Oosterhuis J. W., Oosterhuis A. M., Ramaekers F. C. Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas. Hum Pathol. 1985 Aug;16(8):838–843. doi: 10.1016/s0046-8177(85)80256-2. [DOI] [PubMed] [Google Scholar]
  26. Osborn M., Weber K. Intermediate filaments: cell-type-specific markers in differentiation and pathology. Cell. 1982 Dec;31(2 Pt 1):303–306. doi: 10.1016/0092-8674(82)90122-2. [DOI] [PubMed] [Google Scholar]
  27. Osborn M., Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983 Apr;48(4):372–394. [PubMed] [Google Scholar]
  28. Ramaekers F. C., Haag D., Kant A., Moesker O., Jap P. H., Vooijs G. P. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci U S A. 1983 May;80(9):2618–2622. doi: 10.1073/pnas.80.9.2618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ramaekers F., Puts J., Kant A., Moesker O., Jap P., Vooijs P. Differential diagnosis of human carcinomas, sarcomas and their metastases using antibodies to intermediate-sized filaments. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1251–1257. doi: 10.1016/0277-5379(82)90126-2. [DOI] [PubMed] [Google Scholar]
  30. Rowland F. N., Donovan M. J., Lindsay M., Weiss W. I., O'Rourke J., Kreutzer D. L. Demonstration of inflammatory mediator-induced inflammation and endothelial cell damage in the anterior segment of the eye. Am J Pathol. 1983 Jan;110(1):1–12. [PMC free article] [PubMed] [Google Scholar]
  31. Viac J., Reano A., Brochier J., Staquet M. J., Thivolet J. Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol. 1983 Oct;81(4):351–354. doi: 10.1111/1523-1747.ep12519941. [DOI] [PubMed] [Google Scholar]
  32. Vogel A. M., Gown A. M., Caughlan J., Haas J. E., Beckwith J. B. Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins. Lab Invest. 1984 Feb;50(2):232–238. [PubMed] [Google Scholar]
  33. Wells C. A., Heryet A., Brochier J., Gatter K. C., Mason D. Y. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer. 1984 Aug;50(2):193–197. doi: 10.1038/bjc.1984.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. van Muijen G. N., Ruiter D. J., Warnaar S. O. Intermediate filaments in Merkel cell tumors. Hum Pathol. 1985 Jun;16(6):590–595. doi: 10.1016/s0046-8177(85)80108-8. [DOI] [PubMed] [Google Scholar]
  35. van Muijen G. N., Ruiter D. J., van Leeuwen C., Prins F. A., Rietsema K., Warnaar S. O. Cytokeratin and neurofilament in lung carcinomas. Am J Pathol. 1984 Sep;116(3):363–369. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES